Tag Archives: investors

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers


The 17th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place last week in New York City at the Waldorf Astoria with more than 1,400 registrants, including 620 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 5 fireside chats with biotech and pharma CEOs as well as nearly 170 company presentations. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotech Stocks: Perspective in a Bull Market

biotech companies

Investors are increasingly interested in biotechnology based on scientific breakthroughs, an improved regulatory environment, strong earnings growth from large companies, and a more mature industry. Recent advancements in biotechnology are revolutionizing treatments and cures for many illnesses, creating new value for the healthcare system. In 2013, our understanding of how therapeutics can be used to harness the immune system to destroy cancer cells exploded with many companies reporting solid data in human testing. In 2014, Read More >

Inside BIO Industry Analysis  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels

Jim Greenwood

The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its bipartisan supporters intended, spurred major domestic and international investment in US biofuels production and it is essential to maintaining a growing market for second generation biofuels. That growing market helps attract investment to advanced biofuel companies who are trying to expand their infrastructure, scale up their production line, and improve their technology foundation. Unfortunately, the Environmental Protection Agency’s (EPA) recent Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Dave Thomas

Is 2014 a good time to invest in biotech? How many biotech IPOs will there be? Which sectors will perform the best? To find out what investors think about these questions and more, BIO is conducting its annual Buy-side Investor Perception Survey and releasing the results at the 16th Annual BIO CEO & Investor Conference in New York, Monday Feb. 10. But as the results are coming in, BIO is hosting the #BIOBuyside Twitter chat Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,